TFF Pharmaceuticals Q4 EPS $(2.01) Beats $(2.12) Estimate, Sales $114.33K Beat $100.00K Estimate
Author: Benzinga Newsdesk | March 28, 2024 04:20pm
TFF Pharmaceuticals (NASDAQ:
TFFP) reported quarterly losses of $(2.01) per share which beat the analyst consensus estimate of $(2.12) by 5.19 percent. This is a 19.6 percent increase over losses of $(2.50) per share from the same period last year. The company reported quarterly sales of $114.33 thousand which beat the analyst consensus estimate of $100.00 thousand by 14.33 percent. This is a 63.45 percent decrease over sales of $312.78 thousand the same period last year.
Posted In: TFFP